Retrospective Study to Capture Dosing and Treatment Outcome Data in Participants With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Baxalta now part of Shire
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participant treated with protein C concentrate under a Baxter Healthcare Corporation Emergency Use IND.
Participant with diagnosis of severe congenital protein C deficiency.
Participant or parent/legally authorized representative has provided written informed consent.
Clareo Health | Retrospective Study to Capture Dosing and Treatment Outcome Data in Participants With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND
